文献速递类风湿关节炎

超声对早期类风湿关节炎关节腔内糖皮质激素注射使用及疗效的影响:一项随机试验的二次分析,该试验考察超声在临床严密控制方案中的获益

The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control Regimen.
PubMed 文献 · Arthritis Rheumatol · 2018-06-29

该研究为ARCTIC随机试验的二次分析,纳入早期类风湿关节炎患者,随机1:1接受超声随访或常规随访。结果显示超声组关节腔内注射次数多于常规组(770次 vs 548次),注射时超声评估的滑膜血流可区分注射疗效,但超声引导与触诊引导注射的疗效相似。

要点

  • 超声组关节腔内注射次数多于常规组(770次 vs 548次),腕间关节和跖趾关节注射更多。
  • 临床肿胀但超声无能量多普勒活动的关节,注射与不注射相比无显著疗效差异(OR 1.3,P=0.59)。
  • 超声引导与触诊引导注射的治疗成功率相似。

核心结论

  • 关节腔内糖皮质激素注射的疗效因注射时超声所见而异,支持使用超声作为选择可从关节腔内注射获益的关节的工具。
  • 超声引导针头并不优于触诊引导。

研究设计与样本

  • 研究为ARCTIC随机试验的二次分析,早期类风湿关节炎患者随机1:1接受超声随访或常规随访(不超声)。
  • 在改善病情抗风湿药基础上,对炎症关节使用关节腔内糖皮质激素注射。
  • 评估两组注射分布,分析注射时临床与超声所见与疗效的关系,以末次访视时关节无肿胀为结局指标。

主要发现

  • 超声组注射次数多于常规策略组(770次 vs 548次),腕间关节(58次 vs 5次)和跖趾关节(200次 vs 104次)注射更多。
  • 临床肿胀但超声无能量多普勒活动的关节,注射与不注射相比无显著疗效差异(OR 1.3;P=0.59)。
  • 有中度能量多普勒活动的肿胀关节(OR 9.0;P=0.001)和无肿胀关节(OR 8.4;P=0.016)注射疗效最佳。
  • 超声引导与触诊引导注射的治疗成功率相似。

关键数值与推荐

  • 临床肿胀但超声无能量多普勒活动关节的注射疗效:OR 1.3;P=0.59。
  • 有中度能量多普勒活动的肿胀关节注射疗效:OR 9.0;P=0.001。
  • 有中度能量多普勒活动的无肿胀关节注射疗效:OR 8.4;P=0.016。

临床怎么用

  • 研究结论支持使用超声作为选择可从关节腔内注射获益的关节的工具。
  • 超声引导针头并不优于触诊引导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intraarticular glucocorticoid injections are common in rheumatoid arthritis (RA) treatment. This study was undertaken to investigate whether ultrasound in combination with clinical examination is better than clinical examination alone at identifying joints that will benefit from intraarticular injections, and to compare the efficacy of ultrasound-guided versus palpation-guided procedures. METHODS: In the treat-to-target Aiming for Remission in Rheumatoid Arthritis: a Randomised Trial Examining the Benefit of Ultrasonography in a Clinical Tight Control Regimen (ARCTIC), patients with early RA were randomized 1:1 to follow-up with or without ultrasound. In addition to disease-modifying antirheumatic drugs, intraarticular glucocorticoids were used to treat inflamed joints. The distribution of injections was assessed in both study groups. The relationship of clinical and ultrasound findings at the time of injection with treatment efficacy was examined, with non-swollen joint at the next visit as the outcome measure. Treatment success was compared across study groups to evaluate ultrasound-guided versus palpation-guided procedures. RESULTS: More injections were administered in the ultrasound group than in the conventional strategy group (n = 770 versus 548), especially in intercarpal joints (n = 58 versus 5) and metatarsophalangeal joints (n = 200 versus 104). Injecting clinically swollen joints without power Doppler (PD) activity on ultrasound was not efficacious compared to not injecting (odds ratio [OR] 1.3; P = 0.59). Efficacy was best in swollen joints (OR 9.0; P = 0.001) and non-swollen joints (OR 8.4; P = 0.016) with moderate PD activity. Treatment success was similar for the ultrasound-guided and palpation-guided procedures. CONCLUSION: Our findings indicate that the efficacy of intraarticular glucocorticoid injections varies according to ultrasound findings at the time of injection, supporting the use of ultrasound as a tool to select joints that will benefit from intraarticular injections. However, ultrasound needle guidance was not superior to palpation guidance.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Nordberg LB, Lillegraven S, Aga AB, et al. The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control Regimen. Arthritis Rheumatol. 2018. PMID: 29575737. doi:10.1002/art.40494

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。